Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports

RBC Life Science and Technology Fund Series A

U.S. Equity

FundGrade A Click for more information on Fundata’s FundGrade

FundGrade A

Click for more information on Fundata’s FundGrade.

Fundata ESG GradeA Click for more information on Fundata’s ESG Grade

Fundata ESG Grade A

Click for more information on Fundata’s ESG Grade.

FundGrade A+® Rating Recipient

FundGrade A+® Rating Recipient

2024, 2023, 2022, 2021, 2020

Click for more information on Fundata’s FundGrade

NAVPS
(06-13-2025)
$52.08
Change
-$0.76 (-1.44%)

As at May 31, 2025

As at April 30, 2025

As at May 31, 2025

Period
Created with Highcharts 10.3.3Jan 2024Jul 2022Oct 2022Jan 2023Apr 2023Jul 2023Oct 2023Apr 2024Jul 2024Oct 2024Jan 2025Apr 2025Jan 2000Jan 2005Jan 2010Jan 2015Jan 2020Jan 2025J…$10,000$7,500$12,500$15,000$17,500$20,000Period

Legend

RBC Life Science and Technology Fund Series A

Compare Options


Fund Returns

Inception Return (July 31, 1995): 8.00%

Fund Returns
Row Heading Return Annualized Return
1 Mth 3 Mth 6 Mth YTD 1 Yr 2 Yr 3 Yr 4 Yr 5 Yr 6 Yr 7 Yr 8 Yr 9 Yr 10 Yr
Fund 6.50% -6.17% -4.35% -6.47% 9.36% 19.98% 19.66% 13.59% 14.44% 16.77% 15.41% 15.35% 16.52% 14.28%
Benchmark 5.88% -5.07% -3.12% -3.37% 14.53% 21.32% 17.67% 14.22% 15.90% 15.75% 14.67% 14.04% 14.79% 14.00%
Category Average 5.26% -4.85% -5.13% -3.50% 9.43% 16.98% 12.94% 9.20% 12.41% 11.86% 10.74% 10.50% 11.05% 10.02%
Category Rank 336 / 1,332 822 / 1,310 570 / 1,297 1,092 / 1,298 712 / 1,274 400 / 1,208 122 / 1,157 141 / 1,081 249 / 1,019 46 / 952 56 / 874 63 / 814 41 / 738 53 / 650
Quartile Ranking 2 3 2 4 3 2 1 1 1 1 1 1 1 1

Monthly Return

Created with Highcharts 10.3.3-10%-5%0%5%10%
Monthly Return
Return % Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May
Fund 7.16% -1.22% 0.19% 1.64% 1.85% 4.13% 2.27% 3.31% -3.51% -8.81% -3.40% 6.50%
Benchmark 3.97% 2.12% 0.07% 2.23% 2.12% 6.59% 0.26% 3.46% -1.62% -6.04% -4.57% 5.88%

Best Monthly Return Since Inception

37.88% (February 2000)

Worst Monthly Return Since Inception

-21.85% (February 2001)

Calendar Return (%)

Created with Highcharts 10.3.3-40%-20%0%20%40%60%
Calendar Return
Return % 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fund 21.81% -0.84% 22.08% 8.77% 25.94% 29.23% 24.97% -22.89% 37.42% 37.19%
Benchmark 20.77% 8.65% 13.80% 3.98% 25.18% 16.07% 28.16% -12.52% 23.32% 36.01%
Category Average 10.40% 6.16% 13.43% -2.19% 22.72% 13.97% 23.22% -14.41% 18.85% 26.98%
Quartile Ranking 1 4 1 1 2 1 2 4 1 1
Category Rank 84/ 634 588/ 682 109/ 759 90/ 844 305/ 916 137/ 991 422/ 1,056 886/ 1,107 107/ 1,170 233/ 1,256

Best Calendar Return (Last 10 years)

37.42% (2023)

Worst Calendar Return (Last 10 years)

-22.89% (2022)

Asset Allocation

Asset Allocation
Name Percent
US Equity 93.16
International Equity 4.74
Cash and Equivalents 1.56
Canadian Equity 0.52
Other 0.02

Sector Allocation

Sector Allocation
Name Percent
Technology 66.99
Healthcare 21.50
Consumer Services 3.61
Financial Services 2.57
Telecommunications 1.59
Other 3.74

Geographic Allocation

Geographic Allocation
Name Percent
North America 95.24
Europe 4.02
Latin America 0.53
Asia 0.19
Other 0.02

Top Holdings

Top Holdings
Name Percent
Microsoft Corp 9.45
Apple Inc 9.37
NVIDIA Corp 8.44
Alphabet Inc Cl A 7.30
Meta Platforms Inc Cl A 5.93
Broadcom Inc 3.44
Eli Lilly and Co 3.10
UnitedHealth Group Inc 2.63
Netflix Inc 2.13
Abbvie Inc 1.95

Equity Style

Market capitalization is large. Equity style is growth.

Fixed Income Style

Fixed income style data not available
Period: 

Risk vs Return (3 Yr)

Created with Highcharts 10.3.3Risk (Annualized Standard Deviation)ReturnMedian DeviationMedian Return810121416182022242628-5%0%5%10%15%20%25%30%

RBC Life Science and Technology Fund Series A

Median

Other - U.S. Equity

3 Yr Annualized

Standard Deviation 15.56% 15.56% 15.24%
Beta 1.00% 1.07% 1.07%
Alpha 0.02% -0.02% 0.00%
Rsquared 0.83% 0.86% 0.85%
Sharpe 0.98% 0.79% 0.84%
Sortino 1.75% 1.17% 1.21%
Treynor 0.15% 0.11% 0.12%
Tax Efficiency 100.00% 100.00% 100.00%
Volatility Volatility rating is 8 on a scale of 1 to 10 Volatility rating is 9 on a scale of 1 to 10 Volatility rating is 9 on a scale of 1 to 10

Risk Rating

Rating 8 out of ten

Annualized Key Ratio Period Comparison

Key Ratio
Key Ratio 1 Yr 3 Yr 5 Yr 10 Yr
Standard Deviation 15.74% 15.56% 15.56% 15.24%
Beta 1.07% 1.00% 1.07% 1.07%
Alpha -0.05% 0.02% -0.02% 0.00%
Rsquared 0.81% 0.83% 0.86% 0.85%
Sharpe 0.42% 0.98% 0.79% 0.84%
Sortino 0.67% 1.75% 1.17% 1.21%
Treynor 0.06% 0.15% 0.11% 0.12%
Tax Efficiency 100.00% 100.00% 100.00% 100.00%

Fundata ESG Metrics

Fundata ESG Score

Created with Highcharts 10.3.3Grade: EGrade: DGrade: CGrade: BGrade: A91.491.461.761.70%10%20%30%40%50%60%70%80%90%100%

The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.

Fundata E Score

Created with Highcharts 10.3.3Grade: EGrade: DGrade: CGrade: BGrade: A94.294.262.562.50%10%20%30%40%50%60%70%80%90%100%

Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.

Fundata S Score

Created with Highcharts 10.3.3Grade: EGrade: DGrade: CGrade: BGrade: A84.184.155.555.50%10%20%30%40%50%60%70%80%90%100%

Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.

Fundata G Score

Created with Highcharts 10.3.3Grade: EGrade: DGrade: CGrade: BGrade: A87.987.964.964.90%10%20%30%40%50%60%70%80%90%100%

Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.

Powered by OWL Analytics. For more information, please contact Fundata Canada.

Fund Details

Start Date July 31, 1995
Instrument Type Mutual Fund
Share Class Commission Based Advice
Legal Status Trust
Sales Status Open
Currency CAD
Distribution Frequency Annual
Assets ($mil) $2,299

Fund Codes

FundServ Code Load Code Sales Status
RBF274

Investment Objectives

The objective of the fund is to provide long-term capital growth. The fund invests primarily in equity securities of U.S. companies whose businesses relate to life sciences and technology and are expected to benefit from scientific and technological advances.

Investment Strategy

The fund’s investment process is primarily based on fundamental research, although the portfolio manager will also consider quantitative and technical factors. Stock selection decisions are ultimately based on an understanding of the company, its business and its outlook. Life science investments include biotechnology, medical devices and services, pharmaceuticals and medical instruments.

Portfolio Management

Portfolio Manager

RBC Global Asset Management Inc.

  • Rob Cavallo
  • Marcello Montanari
Sub-Advisor

-

Management and Organization

Fund Manager

RBC Global Asset Management Inc.

Custodian

RBC Investor Services Trust (Canada)

Registrar

RBC Global Asset Management Inc.

Royal Bank of Canada

RBC Investor Services Trust (Canada)

Distributor

Royal Mutual Funds Inc.

Investment Minimums

RSP Eligible Yes
PAC Allowed Yes
PAC Initial Investment 25
PAC Subsequent 25
SWP Allowed Yes
SWP Min Balance 10,000
SWP Min Withdrawal 100

Fees

MER 2.05%
Management Fee 1.75%
Load No Load
FE Max -
DSC Max -
Trailer Fee Max (FE) -
Trailer Fee Max (DSC) -
Trailer Fee Max (NL) 1.00%
Trailer Fee Max (LL) -

Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports